| Type | Privately held partnership |
|---|---|
| Industry | International consulting firm |
| Founded | October 2001 |
| Headquarters | New York City, New York, U.S. |
| Number of locations | 10 (As of 2010[update]) |
| Area served | Worldwide |
| Employees | <150 |
| Website | dalberg.com |
Dalberg Global Development Advisors is a niche consultancy firm. Founded in 2001, the company specializes in global development and globalization and has coordinated several public-private partnerships.
Contents |
The firm was founded in October 2001 by Henrik Skovby and Søren Peter Andreasen to bring consultants from the private sector to international development organizations. It now has ten offices worldwide, including Copenhagen, Dakar, Geneva, Johannesburg, Mumbai, Nairobi, New York, Santiago, San Francisco, Washington D.C. Its clients include corporations, foundations and NGOs operating in emerging and developing markets and national governments. It has conducted over 400 projects in 75 countries.
Projects include studies for the United Nations, World Bank and the President of Liberia. In 2007, the firm collaborated with the Financial Times and the United Nations Global Compact to provide an assessment of the quality of NGOs and the United Nations' agencies that have established working relationships with private-sector companies.[1][2]
The firm presents the annual I-Qube Award that recognizes innovation, impact, and inspiration in the development field.[3]
Dalberg has advised investment funds for organizations and governments in Asia and Africa, including investments in wind energy projects in the People's Republic of China and geothermal energy plants in Indonesia. Dalberg recommended energy-sector reforms to the Government of Montenegro, and advised a U.S. think-tank on the energy markets in Pakistan and the Middle East.
In Tanzania, the firm provided advice on strategies to meet Millennium Development Goals energy targets by 2012. A new drug, known as the Artemisinin-based combination therapies (ACTs), was available to combat malaria, but was largely inaccessible to the masses because of cost and distribution challenges.[4] The World Bank commissioned Dalberg to design a mechanism to reduce the cost of ACTs.[5] In November 2007, the design for the Affordable Medicines Facility – malaria (AMFm) was approved by the Roll Back Malaria (RBM) Partnership Board.[6] Other projects in this sector have included designing initiatives to support people with chronic diseases in developing countries and advising pharmaceutical companies in Venezuela on profitable growth.
In 2006-2007, the President of Liberia, Ellen Johnson Sirleaf, asked the firm to study poverty reduction. Dalberg presented Sirleaf and the Liberian Cabinet case studies of similar African countries such as Rwanda and Mozambique and highlighted the potential trade-offs that Liberia had to make to overhaul of its economy in the wake of the second civil war.[7]
Media related to [//commons.wikimedia.org/wiki/Category:Dalberg_Global_Development_Advisors Dalberg Global Development Advisors] at Wikimedia Commons